Multimodality treatment with intensity modulated radiation therapy for esophageal cancer

Diseases of the Esophagus

Volumn 23, Issue 4, 2010, Pages 300-308

  La, T H ^a   Minn, A Y ^a   Su, Z ^a   Fisher, G A ^a   Ford, J M ^a   Kunz, P ^a   Goodman, K A ^b   Koong, A C ^a   Chang, D T ^a  

^a STANFORD UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Esophageal cancer; Intensity modulated radiation therapy (IMRT); Local control; Outcomes; Radiation toxicity

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; CAPECITABINE; CARBOPLATIN; CISPLATIN; FLUOROURACIL; MITOMYCIN C; OXALIPLATIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; AGED; ARTICLE; ASTHMA; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DESQUAMATION; DIGESTIVE SYSTEM PERFORATION; DISEASE DURATION; DISEASE EXACERBATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DYSPHAGIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; GASTROSTOMY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMATOLOGIC DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; JEJUNOSTOMY TUBE; LOWER ESOPHAGUS SPHINCTER; LUNG DISEASE; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; POSTGASTRECTOMY SYNDROME; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; THERAPY DELAY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; UPPER RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION; ADENOCARCINOMA; ESOPHAGUS TUMOR; FEASIBILITY STUDY; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RADIATION DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78049418696     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.01004.x     Document Type: Article

References (24)

1. al-Sarraf M, Martz K, Herskovic A et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997; 15: 277-84.
2. Bosset J-F, Gignoux M, Triboulet J-P et al. Chemotherapy followed by surgery compared with surgery alone in squamouscell carcinomas of the esophagus. N Engl J Med 1997; 337:161-7.
3. Cooper J S, Guo M D, Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999; 281: 1623-7.
4. Herskovic A, Martz K, al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326:1593-8.
5. Urba S G, Orringer M B, Turrisi A, Iannettoni M, Forastiere A, Strawderman. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-13.
6. Walsh T N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
7. Minsky B D, Pajak T F, Ginsberg R J et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20:1167-74.
8. Chandra A, Guerrero T M, Liu H H et al. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol 2005; 77: 247-53.
9. Nutting CM, Bedford J L, Cosgrove V P, Tait DM, Dearnaley DP, Webb S. A comparison of conformal and intensitymodulated techniques for oesophageal radiotherapy. Radiother Oncol 2001; 61: 157-63.
10. Wang S L, Liao Z, Liu H et al. Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 2006; 12: 5501-508.
11. AJCC. Cancer Staging Handbook, 6th edn. New York, NY: Springer-Verlag, 2002.
12. Cancer therapy evaluation program, common terminology criteria for adverse events, version 3.0. 2003. Available from URL: http://ctep.cancer.gov.
13. Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
14. Cox D. Regression models and life tables. J R Stat Soc [Ser B] 1972; 34: 187-229.
15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70.
16. Kaklamanos I G, Walker G R, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003; 10: 754-61.
17. Urschel M D, Vasan H. A meta-analysis for randomized controlled trials that compared neo-adjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-43.
18. Zhang Z, Liao Z, Jin J et al. Dose-response relationship in local-regional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61: 656-64.
19. Sun D R. Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. Int J Radiat Oncol Biol Phys 1989; 16: 329-34.
20. Stahl M, Stuschke M, Lehmann N et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23:2310-7.
21. Bedenne L, Michel P, Bouche O et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160-8.
22. Reynolds J V, Muldoon C, Hollywood D et al. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 2007; 245: 707-16.
23. Rice T W, Blackstone E H, Adelstein D J et al. N1 esophageal carcinoma: the importance of staging and downstaging. J Thorac Cardiovasc Surg 2001; 121: 454-64.
24. Suntharalingam M, Haas M L, Sonett J R et al. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma. Cancer J 2001; 7: 509-15.